Search
Pentobarbital
go.drugbank.com/drugs/DB00312ApprovedVet approvedIt is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration.
Products: Novo-pentobarb 100mg, Nembutal Sodium Cap 100mgCetirizine
go.drugbank.com/drugs/DB00341ApprovedInvestigationalAllergic rhinitis is associated with multiple missed or unproductive days at work and school, problems with sleep, and other difficulties with day to day activities for many individuals [A175057].
Mixtures: Cetirizine HCl and Pseudoephedrine HCl ER, Cetirizine HCl and Pseudoephedrine HCl ERProducts: CETIDEX 10MG, CETIXIN 10MGGlimepiride
go.drugbank.com/drugs/DB00222ApprovedInvestigationalIt is sometimes classified as a third-generation SU because it has larger substitutions than other second-generation SUs. … It is commonly marketed under the brand name Amaryl as oral tablets and is typically administered once daily.
Mixtures: GLIMET 1mg/500mg SUSTAINED RELEASE TABLETS, AMARYL®M 2MG/1000MGProducts: GLIMEPIRID - CT 1MG, GLIMEPIRID HEUMANN 1MG NETRocuronium
go.drugbank.com/drugs/DB00728ApprovedInvestigationalIt is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. … It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery
Products: ZEMUROC® 10MG/ML, Rocuronium-hameln 10mg/ml InjectionEnoxaparin
go.drugbank.com/drugs/DB01225ApprovedInvestigationalInitially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies.
Products: CLEXANE T, TROMBENOX TNilotinib
go.drugbank.com/drugs/DB04868ApprovedInvestigationalNilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). A Phase I clinical trial in 2006 showed that this drug was relatively safe and offered si...
Products: Tasigna Capsule 200mg, TASIGNA 200MG CAPSULELorazepam
go.drugbank.com/drugs/DB00186ApprovedInvestigational[A957] It was developed by DJ Richards, presented and marketed initially by Wyeth Pharmaceuticals in the USA in 1977.
Products: LORAZEPAM EG, Ativan Tab 2mgTilmicosin
go.drugbank.com/drugs/DB11471InvestigationalVet approvedIt is used in veterinary medicine for the treatment of bovine respiratory disease and ovine respiratory disease associated with _Mannheimia haemolytica_.
Products: TIMECOTIL 100MG/ML SOLUTION, TILCOSIN 100mg/ml Oral SolutionEmpagliflozin
go.drugbank.com/drugs/DB09038ApprovedInvestigational[A203501] Attempts at overcoming these limitations first saw the development of O-glucoside analogs of phlorizin (e.g. … [A203453] It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus.
Mixtures: Glyxambi Film-Coated Tablets 10mg/5mg, GLYXAMBI 10MG/5 MG FİLM KAPLI TABLET, 30 TABLETProducts: JARDIANCE FILM-COATED TABLETS 10MG, Jardiance 10mg film coated tabletsLixisenatide
go.drugbank.com/drugs/DB09265ApprovedInvestigationalIt is sold by Sanofi-Aventis under the brand name Adlyxin in the US[L763] and Lyxumia in the EU.[L764] Adlyxin recieved FDA approval July 28, 2016.[L763]
Mixtures: LYXUMIA SOLUTION FOR INJECTION IN PRE-FILLED PEN 10MCG AND 20MCG (50mcg/mL and 100mcg/mL), LYXUMIA SOLUTION FOR INJECTION IN PRE-FILLED PEN 10MCG AND 20MCG (50mcg/mL and 100mcg/mL)Products: Lyxumia 20mcg Solution for Injection, Lyxumia 10mcg Solution for Injection